Manuel Mayrdorfer Denmark
Manuel Maximilian Mayrdorfer is an Associate Medical Director at Novo Nordisk, based in Denmark, working within Global Medical Affairs with a focus on chronic kidney disease and cardiometabolic medicine. He has a background in academic nephrology, with prior affiliations at the Nephrology Departments of Charité - Universitätsmedizin Berlin and the Medical University of Vienna, where his research focused on kidney transplant recipients. His current work focuses on the design and interpretation of late‑phase clinical trials in chronic kidney disease, with particular emphasis on endpoint strategy and the scientific communication of trial results.
29 March 2026
| Time | Session |
|---|---|
|
3:50 p.m.
4:50 p.m.
|